An observational study in Cardiovascular Diseases, Surgery and Hypotension, sponsored by Recep Tayyip Erdogan University. Recruiting at 5 sites in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-09.
Sponsored by Recep Tayyip Erdogan University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 96 studies in Hypotension with a site in Turkey — 34 open to participants now, 35 under way, none of them phase 3. Hypotension · Turkey.
Among the 96 studies in Hypotension with a site in Turkey, this one is the 2nd largest by planned enrollment of the 62 observational ones that give a count, is one of 11 that started in 2024, is one of 62 observational ones, reaches primary completion later than 20 of the 34 other live ones, and was the 32nd registered.
892 studies on the registry are indexed under Hypotension; 199 are open to participants now.
Browse Hypotension studies →34 of the 96 studies in Hypotension with a site in Turkey are open now. Recruiting first, the newest first:
Kayseri City Hospital · Sites in Turkey
Ages 18+ · Women only
Ankara City Hospital Bilkent · Sites in Turkey
Ages 18+
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · Sites in Turkey
Ages 18+
Ankara Etlik City Hospital · Sites in Turkey
Ages 18–65
Ordu University · Sites in Turkey
Ages 18–40 · Women only
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 114 Hypotension studies recruiting now, 53 (46%) set no upper age limit and 36 (32%) stop at 75 or younger; 7 take children under 18; 16 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
96 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 11 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 660 is above the median of 93 across 269 observational studies indexed under Hypotension.
Median enrollment 101 across the 34 interventional studies, 100 across the 62 observational. Of the 53 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 96 has an industry lead sponsor. The 10 most frequent:
Recep Tayyip Erdogan University is the lead sponsor of 69 studies on the registry; 13 are open to participants now.
Recep Tayyip Erdogan University has 1 study filed under Hypotension — fewer than ten, so there is no comparison to draw.
17 of the studies in Hypotension with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07794852Istanbul UniversityDural Sac Area-Guided Spinal Anesthesia Dosing for TURP | 2026-11-24 |
| NCT05993481Konya City HospitalThe Noninvasive Blood Pressure Measurement Effect on the Hypotension | 2026-11-25 |
| NCT07539896Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalThe Role of Preoperative Internal Jugular Vein Collapsibility and Perfusion Index in Predicting Hypotension After Spinal Anesthesia in Elective Cesarean Sections: A Prospective Observational Study | 2026-11-25 |
| NCT05960604Recep Tayyip Erdogan UniversityPressure Recording Analytical Method Parameters and Their Relationship With Hypotension in Hypertensive Patients | 2026-12 |
| NCT07777159Ankara City Hospital BilkentCarotid Doppler Changes After Passive Leg Raising for Prediction of Post-Induction Hypotension in Gastrointestinal Tumor Surgery | 2026-12 |
Add all 17 to your calendar (.ics) → With an account.
Among the 96 studies in Hypotension with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Perioperative anesthesiologists can benefit from easily obtainable hemodynamic variables detecting or quantifying the lack of an adequate compensatory capacity of the cardiovascular system in order to optimize patient management and improve patient outcomes. Parameters of the Pressure Recording Analytical Method (PRAM; Vygon, Padua, Italy) of the MostCare system, specifically cardiac cycle efficiency has been proposed as such variables. Yet, their value in anesthesia and especially in hypertensive patients is not studied. The goal of the PRAM-in-HYPO study is to prospectively evaluate the relationship between cardiac reserve and efficiency and cardiovascular risk factors in patients wo will undergo major surgical procedures using the state-of-the-art hemodynamic monitors. Also the investigators aim to build a predictive model to identify patients with decreased cardiac reserve due to hypertension and other cardiovascular risk factors, who are susceptible to post-induction hypotension. The investigators seek to include high-risk patients or patients presenting for major surgery, who are monitored with an advanced hemodynamic monitor to adequately evaluate the differences in cardiac reserve and cardiac efficiency.
Untreated hypertension decreases the cardiac reserve through several mechanisms, which are augmented by other cardiovascular risk factors such as diabetes mellitus and coronary artery disease. Perioperative stress on top of these overlapping diseases causes wide variations in the arterial blood pressure. From the anesthesiologist's point of view, this translates into a wide variation in response to surgical stress among patients with seemingly similar cardiovascular risk factors.
The cardiac reserve may be measured by cardiac catheterization or echocardiography, none of which are feasible during a surgery. Recently, some parameters of the Pressure Recording Analytical Method (PRAM) were shown to be affected by hypertension or intraoperative events such as pneumoperitoneum and position changes. This suggests that PRAM may be used to evaluate the risk of adverse hemodynamic events in newly diagnosed, untreated hypertensive patients.
The investigators hypothesized that there is a relationship between hypertension, diabetes mellitus and decreased cardiac reserve and efficiency and that PRAM parameters may identify this. Also, the static or dynamic PRAM parameters may predict pre-incision hypotension in patients wo will undergo major surgical procedures.
In order to test these hypothesis, a prospective cohort study was planned, as the outcome has a very short latency and the intent is to observe the outcome, not to prevent or treat it. The investigators aim to collect high quality hemodynamic data from normotensive, hypertensive, and untreated hypertensive patients. In order to obtain sufficient relevant data, only patients scheduled for major surgeries will be included. Patients who are planned to be monitored with the MostCare hemodynamic monitor, and who need a passive leg raising test will be included in the study.
Hypertension is the most prevalent of cardiovascular risk factors, namely diabetes mellitus, coronary artery disease, smoking, obesity, and dyslipidemia, which may present as either the mediator or cofounder of hypertension. Therefore a detailed medical history including information relevant to these conditions will be collected.
892 studies on the registry are indexed under Hypotension; 199 are open to participants now.
This study's planned enrollment of 660 is above the median of 93 across 269 observational studies indexed under Hypotension.
Browse Hypotension studies →Recep Tayyip Erdogan University is the lead sponsor of 69 studies on the registry; 13 are open to participants now.
Compared within Hypotension, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Cardiovascular Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Patients who are scheduled for any major surgery will be included. Major surgery includes a broad list of cardiac surgery, thoracic surgery, hepatic surgery, pancreatic surgery, colorectal surgery, major orthopedic surgeries, cancer surgeries, where blood loss or intravascular volume loss is expected due to factors related to the patient or surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
NYHA class (heart failure)
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
LVEF (left ventricular ejection fraction)
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
GFR and eGFR (kidney filtering)
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients who were identified as having low cardiac reserve and efficiency, based on PRAM parameters.
Diagnostic Test: Passive leg raising
Patients who were identified as having normal cardiac reserve and efficiency, based on PRAM parameters.
Diagnostic Test: Passive leg raising
All patients who met the inclusion criteria will be placed head down flat and feet up at a 45° angle for 30 seconds. Hemodynamic parameters and analysis by pressure recording analytical method obtained with the MostCare will be collected before, during and after the test until the end of the surgery. The total duration of the intervention (passive leg raising) is 30 seconds. The total duration of hemodynamic parameters recording is expected to be 60-600 minutes.
Difference of mean CCE, dP/dt, SVI, CPI, Ea by hypertension and diabetes mellitus
Difference in baseline PRAM parameters between patients who have hypertension, diabetes mellitus and other cardiovascular diseases and those who have none.
Time frame: From the start of surgery until the end of surgery
Difference of mean CCE, dP/dt, SVI, CPI, Ea at the 30th second of passive leg raising by hypertension and diabetes mellitus
Difference in the magnitude of the changes observed in PRAM parameters after a passive leg raising test between patients who have hypertension, diabetes mellitus and other cardiovascular diseases and those who have none.
Time frame: From the start of passive leg raising test until the end of the test
Number of Participants With Mean Arterial Blood Pressure < 65 mmHg Within 5 Minutes Following Tracheal Intubation
Hypotension, defined as mean arterial blood pressure \< 65 mmHg, within 5 minutes after tracheal intubation.
Time frame: From the start of surgery until the end of surgery
Number of Participants With Mean Arterial Blood Pressure < 65 mmHg Between Tracheal Intubation and Surgical Incision
Hypotension, defined as mean arterial blood pressure \< 65 mmHg, between 5 minutes after tracheal intubation and surgical incision.
Time frame: From the start of surgery until the end of surgery
Number of Participants With Mean Arterial Blood Pressure < 65 mmHg During the Surgery
Hypotension, defined as mean arterial blood pressure \< 65 mmHg, between surgical incision and end of surgery.
Time frame: From the start of surgery until the end of surgery
Predictive factors of hypotension
Identification of patient characteristics and arterial pressure waveform parameters associated with hypotension. A multiple logistic regression analysis will be performed.
Time frame: From the start of surgery until the end of surgery
Time to discharge from PACU
Time (hours) required for discharge from the post-anesthesia care unit.
Time frame: From the end of surgery until the discharge from the post anesthesia care unit, up to 7 days
Time to extubation
Time (hours) required for tracheal extubation.
Time frame: From the end of surgery until the tracheal extubation, up to 7 days
Time to discharge from ICU
Time (days) required for discharge from the intensive care unit.
Time frame: From the end of surgery until the discharge from the intensive care unit, up to 7 days
Time to discharge from hospital
Time (days) required for discharge from the hospital.
Time frame: From the end of surgery until the discharge from the hospital, up to 7 days
MINS7
Myocard injury in non-cardiac surgery (MINS) during the first 7 postoperative days.
Time frame: From the end of surgery until the discharge from the hospital, up to 7 days
MACE7
Major adverse cardiac events (MACE) during the first 7 postoperative days.
Time frame: From the end of surgery until the discharge from the hospital, up to 7 days
MAKE7
Major adverse kidney events (MAKE) during the first 7 postoperative days.
Time frame: From the end of surgery until the discharge from the hospital, up to 7 days
Survival
Course of the patient defined as either alive, dead in ICU, or dead in hospital
Time frame: From the end of surgery until the discharge from the hospital, up to 7 days
Days out of hospital 30
On postoperative day 30, the number of days spent outside the hospital (while being alive and free from disability) will be documented, utilizing either healthcare records or through telephone communication with the participating volunteers.
Time frame: From the end of surgery until postoperative day 30
Plan to share: Undecided — The Ethics Committee's approval is required to make individual participant data available to other researchers.
Started Feb 2024 (actual). Primary completion is estimated for Dec 2026, 34 months after the start.
Of 149 non-industry observational studies under Hypotension, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 25. This study's planned 34 months is above that.
Counting every sponsor, half of 154 studies reached it within 11 months; a quarter within 5 and three quarters within 25.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Recep Tayyip Erdogan University